An upregulation of pore-forming claudin-2 and downregulation of sealing claudin-3 has been reported in ulcerative colitis, as well as in experimental colitis models, leading to altered TJ structure and barrier dysfunction [19,20,21,22]. This evidence concerns the gene CLDN2 and colitis.